Macromolecular derivatives of methotrexate and ferrocene as potential prodrugs in cancer chemotherapy
Cancerous diseases present a formidable health problem worldwide. While the chemotherapy of cancer, in conjunction with other treatment modalities, has reached a significant level of maturity, efficacious use of such agents is still restricted by numerous pharmacological deficiencies, such as poo...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en |
| Published: |
2010
|
| Online Access: | http://hdl.handle.net/10539/8348 |